Eingabe löschen

Kopfbereich

Hauptnavigation

Novel cell-based immunization technology and functional validation of resulting antibodies

Beschreibung

Development of a novel immunization method in rabbits that improves the generation of antibodies against the native form of human proteins e.g. cell surface receptors. Subsequent validation of the method through functional characterization of candidate therapeutic antibodies in vitro and in vivo. The aim is the discovery of monoclonal antibodies as novel therapeutics for two different first in class targets in cancer.

Eckdaten

Projektleitung

Stellv. Projektleitung

Dr. Bruno Filippi

Co-Projektleitung

Dr. Philippe Krebs, Prof. Dr. Frank Stenner

Projektteam

Bettina Keller Abu Seda, Jenny Pally, Leopold von Balthazar

Projektpartner

Memo Therapeutics AG

Projektstatus

abgeschlossen, 12/2017 - 11/2020

Institut/Zentrum

Institut für Chemie und Biotechnologie (ICBT)

Drittmittelgeber

KTI-Projekt / Projekt Nr. 26019.2 PFLS-LS

Projektvolumen

1'581'835 CHF